Article
The Limits of Molecular Signatures for Pancreatic Ductal Adenocarcinoma Subtyping
2022-05-16
Abstract excerpt
<h4>ABSTRACT</h4> Molecular signatures have been suggested as biomarkers to classify pancreatic ductal adenocarcinoma (PDAC) into two, three or four subtypes. Since the robustness of existing signatures is controversial, we performed a systematic evaluation of three established signatures for PDAC stratification across eight publicly available datasets. Clustering revealed inconsistency of subtypes across indepen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fc5367d-365e-58ae-b56b-8e4036268a8e
- DOI
- 10.1101/2022.05.16.491983
